Compound ID | 169
Class: Antimicrobial peptide
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive |
| Mechanism of action: | Cell division inhibitor. FtsZ inhibitor |
| Target Pathogen: | Active against methicillin-resistant Staphylococcus aureus |
| Description: | A locked nucleic-acid conjugated with the peptide (KFF)3K |
| Institute where first reported: | Department of Pharmacology, School of Pharmacy, Fourth Military Medical University, Xi'an, China |
| Year first mentioned: | 2015 |
| Development status: | Experimental |
| External links: | |
| Citations: |
|